OSIRIS THERAPEUTICS INC NEW's ticker is OSIR and the CUSIP is 68827R108. A total of 64 filers reported holding OSIRIS THERAPEUTICS INC NEW in Q4 2016. The put-call ratio across all filers is 0.39 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2016 | $2,444,000 | -0.4% | 497,743 | +0.6% | 0.00% | – |
Q3 2016 | $2,455,000 | -2.5% | 494,911 | 0.0% | 0.00% | – |
Q2 2016 | $2,519,000 | -13.8% | 494,911 | -3.3% | 0.00% | – |
Q1 2016 | $2,923,000 | -46.0% | 511,991 | -1.9% | 0.00% | -100.0% |
Q4 2015 | $5,415,000 | -43.9% | 521,718 | -0.2% | 0.00% | -50.0% |
Q3 2015 | $9,659,000 | -18.8% | 522,931 | -14.4% | 0.00% | 0.0% |
Q2 2015 | $11,890,000 | +6.1% | 611,012 | -4.1% | 0.00% | 0.0% |
Q1 2015 | $11,203,000 | +11.5% | 637,242 | +1.4% | 0.00% | 0.0% |
Q4 2014 | $10,044,000 | +27.7% | 628,142 | +0.5% | 0.00% | +100.0% |
Q3 2014 | $7,866,000 | -21.5% | 624,747 | -2.6% | 0.00% | -50.0% |
Q2 2014 | $10,024,000 | +24.0% | 641,712 | +4.2% | 0.00% | +100.0% |
Q1 2014 | $8,083,000 | -2.5% | 615,619 | +19.4% | 0.00% | 0.0% |
Q4 2013 | $8,291,000 | -8.4% | 515,622 | -5.2% | 0.00% | -50.0% |
Q3 2013 | $9,050,000 | +63.2% | 543,869 | -1.2% | 0.00% | +100.0% |
Q2 2013 | $5,546,000 | – | 550,723 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|